“…Type I ICD inducers exert multiple cytotoxic effects and trigger ER stress as a secondary mode of action, while type II inducers mediates ROS-related ER-stress as the main mechanism of action (Garg et al, 2015). By far most of the ICD inducers used in clinical anticancer chemotherapy belong to type I class, such as anthracyclines and mitoxantrone, the glycopeptide Measel, 1975;Havarinasab et al, 2007 Stimulates T effector and T suppressor lymphocytes C57BI mice Walz and Griswold, 1978 Low dose promotes MHC II, but high dose inhibits MHC II human monocytes Sanders et al, 1987 Aurothiopropanolsulfonate Enhances the antigen-specific IgE immune response Brown-Norway (BN) rats Kermarrec et al, 1996 HAuCl 4 Activates CD4+T and CD8+T cell, and promotes release of IFN-γ BN rats Savignac et al, 2001 Gold nanoparticles Promotes the immunogenicity of antigens, DC maturation, TLR9 expression, memory CD8+T cells activation, MHC II and CD 86 expression…”